Orbus Therapeutics, Inc.

ACTIVE

2479 E Bayshore Rd Ste 105, 加利福尼亚州圣克拉拉县, California, United Stateswww.orbustherapeutics.comHolding1–10 employeesEstablished: 2012-01-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

71.4%

Phase 3

28.6%

Trial Status Distribution

Active, not recruiting

57.1%

Recruiting

28.6%

Unknown

14.3%

Clinical Trials

Trials sponsored by this organization (7)

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Phase 1

Recruiting

interventional

Jul 202366 participants

A study to measure how well and how safe eflornithine is in combination with lomustine, compared to lomustine taken alone, in treating patients whose anaplastic astrocytoma has got worse or come back after radiation and chemotherapy.

Phase 1

Active, not recruiting

Nov 2018340 participants

A study to measure how well and how safe eflornithine is in combination with lomustine, compared to lomustine taken alone, in treating patients whose anaplastic astrocytoma has got worse or come back after radiation and chemotherapy.

Phase 1

Active, not recruiting

Apr 2017280 participants

A study to measure how well and how safe eflornithine is in combination with lomustine, compared to lomustine taken alone, in treating patients whose anaplastic astrocytoma has got worse or come back after radiation and chemotherapy.

Phase 1

Active, not recruiting

Mar 2017340 participants

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Phase 3

Unknown

interventional

Jul 2016343 participants

A study to measure how well and how safe eflornithine is in combination with lomustine, compared to lomustine taken alone, in treating patients whose anaplastic astrocytoma has got worse or come back after radiation and chemotherapy.

Phase 1

Active, not recruiting

Jun 2016340 participants

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy<br>

Approvals

No approval data available

News

No news articles found

Back to Organizations